department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Henan Cancer Hospital · pharmadog

PUBLIC COMPANY

Henan Cancer Hospital

updated 1mo ago

community read0 votes

pipeline

1

marketed

0

phase 3

0

catalysts ytd

2

approvals ytd

0

recalls ytd

0

Pipeline(1)

pipeline depth1 products

1Unknown

Upcoming

no upcoming catalysts on record

Recent(90d)

phase 1 2 completion (1) · phase 1 completion (1)

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Henan Cancer Hospital jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

mentioned in

0news items

entity-linker matched

phase 1 2 completion

Henan Cancer Hospital — methotrexate (Phase I/II Trial Completion)

phase 1 completion

Henan Cancer Hospital — GH-2616 (Phase I Trial Completion)

Active trials

phase2Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancerrecruitingn=79
phase2A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancercompletedn=60
phase2the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclibenrolling by invitationn=41
EP1RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignanciescompletedn=6
phase2Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02)unknownn=120

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagOncology10 co-mentions · 2 sources
tagBreast Cancer3 co-mentions · 1 sources
tagPulmonology2 co-mentions · 2 sources
tagNSCLC1 co-mentions · 1 sources
tagColorectal Cancer1 co-mentions · 1 sources
drugMETHOTREXATE1 co-mentions · 1 sources
drugMaxtrex1 co-mentions · 1 sources
drugMethotrexate Intas1 co-mentions · 1 sources